Figure 1 Tau PET images in patients with Alzheimer disease

Slides:

Advertisements

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Advertisements

A case of Alzheimer's disease following mild traumatic brain injury

Nat. Rev. Neurol. doi:10/1038/nrneurol

7.3c. Post-Contrast Axial CT of the Brain

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Life expectancy at birth in all countries included

Figure 1 Perivenous distribution of multiple sclerosis lesions

Figure 2 Systemic abnormalities in AD

Figure 2 The US Centers for Disease Control and

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Overview of risk factors for Parkinson disease dementia

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Patterns of brain atrophy in Alzheimer disease

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 General framework of brain–computer interface (BCI) systems

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Proportion of patients for whom NEDA

Figure 4 Neuromyelitis optica spectrum disorder brain lesions

Figure 1 Physiological metabolism of Aβ in the brain and periphery

Figure 1 Diagnostic tiers of Parkinson disease as single disease

Figure 2 Grey matter atrophy in FTD

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 LGI1 and Caspr2 immunohistochemistry on rat brain

Figure 2 Poststroke plasticity and recovery

Figure 1 Principles of therapeutic ultrasound

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Clinical correlates of neurodegeneration in MS

Figure 4 Flow chart of the MDS MSA Study Group aims

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Evolution of multiple sclerosis

Figure 1 The trajectory of cognitive ageing

Figure 4 Generation of tau seeds and spread of tau pathology

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Anatomical location of cerebral microbleeds (CMBs)

Figure 1 Anatomical patterns of neuropathy

Figure 1 Proportional motor recovery in the upper limb

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Diagnostic scheme for MSA

Figure 2 Age-specific prevalence of common comorbidities

Figure 4 11C-PK11195-PET scans showing the evolution of neuroinflammation in a patient after stroke Figure 4 | 11C-PK11195-PET scans showing the evolution.

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Carotid artery inflammation detected using 68Ga-DOTATATE-PET

Figure 6 Combining population-wide and high-risk strategies

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Frequency of vertigo and dizziness syndromes

Figure 3 Potential interplay between physiological

Figure 1 Clinical aspects of LGMD subtypes

Figure 2 Title page of An Essay on the Shaking Palsy

Figure 2 Comparison between noncarriers (−) and carriers (+) of the minor allele of rs (CYP2C19)‏ Comparison between noncarriers (−) and carriers.

In vivo tau imaging: Obstacles and progress

Figure 1 Timing of the effects of deep brain stimulation

Figure 5 Interaction between infarction and amyloid deposition

Figure 1 Flortaucipir PET MUBADA/PERSI SUVr at baseline, 9 and 18 months for individual subjects. Each subject is ... Figure 1 Flortaucipir PET MUBADA/PERSI.

Figure 4 Jean-Martin Charcot (1825–1893)

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Blood–brain barrier breakdown promotes neurodegeneration

Figure 2 A case of early-onset PSD

Figure 2 Global tau-PET distribution in familial prion disease mirrors the distribution seen in Alzheimer disease Global tau-PET distribution in familial.

Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people Oskar Hansson, Sebastian Palmqvist,

Fig. 1. AD biomarker levels in the cerebrospinal fluid of iNPH, AD, and CN subjects. Box plots of Aβ42 (A), Aβ40 (B), Aβ42/Aβ40 ratio (C), t-tau (D),

Fig. 2. Correlation between Aβ42 and Aβ40 levels in iNPH, AD, and CN subjects. The scatter plot shows the correlation between Aβ42 and Aβ40 levels. Representative.

Figure 2 Aβ-PET scans obtained using different tracers

Presentation transcript:

Figure 1 Tau PET images in patients with Alzheimer disease Figure 1 | Tau PET images in patients with Alzheimer disease. Representative images of flortaucipir tau PET signal in the brains of amyloid-β-positive patients with Alzheimer disease. Colour scale shows standard uptake value ratios of Flortaucipir. Arrows highlight patients with comparatively limbic sparing (first row) and limbic predominant (third row) patterns of pathology. Okamura, N. & Yanai, K. (2017) Applications of tau PET imaging Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.38